Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Reunion Neuroscience Inc T.REUN

Healthcare Biotechnology
Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Recent & Breaking News (TSX:REUN)

Reunion Neuroscience (TSX:REUN) commences trading on the TSX

Sabrina Cuthbert August 16, 2022

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

GlobeNewswire August 16, 2022

Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results, Completed Corporate Reorganization on August 11, 2022

GlobeNewswire August 15, 2022

Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing

GlobeNewswire August 11, 2022

Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET

GlobeNewswire August 8, 2022

Field Trip (TSX:FTRP) receives conditional approval to list common shares of Field Trip Health & Wellness on the TSXV

Azuka Onwuka August 5, 2022

Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange

GlobeNewswire August 4, 2022

Field Trip (TSX:FTRP) announces first dosings in Phase 1 clinical study of FT-104

Dave Jackson July 21, 2022

Field Trip Announces First Dosings in Phase I Clinical Study of FT-104

GlobeNewswire July 21, 2022

Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization

GlobeNewswire June 29, 2022

Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies

GlobeNewswire June 29, 2022

Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting

GlobeNewswire June 27, 2022

Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022

GlobeNewswire June 23, 2022

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET

GlobeNewswire June 22, 2022

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date

GlobeNewswire June 14, 2022

Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home

GlobeNewswire May 12, 2022

Field Trip Health (TSX:FTRP) to spin off into two public companies

Trevor Abes  April 29, 2022

Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022

GlobeNewswire April 29, 2022

IIROC Trade Resumption - FTRP

Canada NewsWire April 29, 2022

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

GlobeNewswire April 28, 2022